发明名称 |
PHARMACEUTICAL COMPOSITION OF (R)-1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXY PROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL) CYCLOPROPANECARBOXAMIDE AND ADMINISTRATION THEROF |
摘要 |
<p>A pharmaceutical composition comprising Compound 1, (R)-l-(2,2-difluorobenzo[d][l,3]dioxol-5-yl)-N-(l-(2,3-dihydroxypropyl)-6-fluoro-2-(l-hydroxy-2- methylpropan-2-yl)-lH-indol-5-yl)cyclopropanecarboxamide, and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering the pharmaceutical composition of Compound 1 are also disclosed.</p> |
申请公布号 |
CA2808501(A1) |
申请公布日期 |
2012.03.01 |
申请号 |
CA20112808501 |
申请日期 |
2011.08.22 |
申请人 |
VERTEX PHARMACEUTICALS INCORPORATED |
发明人 |
ALARGOVA, ROSSITZA GUEORGUIEVA;DUNBAR, CRAIG ANTONY;KADIYALA, IRINA NIKOLAEVNA |
分类号 |
A61K9/20;A61K31/404 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|